Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4+CD25++Foxp3+ regulatory T-cells in advanced melanoma patients (Q36972613)

From Wikidata
Jump to navigation Jump to search
scientific article published on 31 May 2013
edit
Language Label Description Also known as
English
Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4+CD25++Foxp3+ regulatory T-cells in advanced melanoma patients
scientific article published on 31 May 2013

    Statements

    Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4+CD25++Foxp3+ regulatory T-cells in advanced melanoma patients (English)
    Laura Ridolfi
    Massimiliano Petrini
    Anna Maria Granato
    Giusy Gentilcore
    Elena Pancisi
    Valentina Ancarani
    Laura Fiammenghi
    Massimo Guidoboni
    Francesco de Rosa
    Linda Valmorri
    Emanuela Scarpi
    Stefania Vittoria Luisa Nicoletti
    Stefano Baravelli
    Angela Riccobon
    Ruggero Ridolfi
    31 May 2013

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit